Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) released its quarterly earnings results on Monday. The company reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.02, Bloomberg Earnings reports. Tabula Rasa Healthcare had a negative return on equity of 6.09% and a negative net margin of 2.27%. The company had revenue of $33.27 million during the quarter, compared to the consensus estimate of $31.76 million. During the same quarter in the prior year, the company posted $0.06 EPS. The firm’s revenue was up 37.6% on a year-over-year basis.

Shares of Tabula Rasa Healthcare (TRHC) opened at $29.90 on Wednesday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.99 and a current ratio of 1.24. Tabula Rasa Healthcare has a 12-month low of $10.39 and a 12-month high of $31.05.

Several analysts recently weighed in on TRHC shares. Piper Jaffray Companies restated a “buy” rating and set a $29.00 target price on shares of Tabula Rasa Healthcare in a research note on Tuesday, October 24th. Chardan Capital increased their target price on Tabula Rasa Healthcare from $19.50 to $21.00 and gave the stock a “buy” rating in a report on Tuesday, August 8th. Stifel Nicolaus restated a “buy” rating and set a $16.00 price target on shares of Tabula Rasa Healthcare in a research report on Friday, July 14th. UBS AG increased their price target on Tabula Rasa Healthcare from $18.00 to $25.00 and gave the stock a “buy” rating in a research report on Wednesday, August 30th. Finally, ValuEngine upgraded Tabula Rasa Healthcare from a “sell” rating to a “hold” rating in a research report on Saturday, September 30th. Two investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $28.25.

In related news, insider Orsula V. Knowlton sold 8,000 shares of Tabula Rasa Healthcare stock in a transaction dated Wednesday, October 18th. The stock was sold at an average price of $26.68, for a total value of $213,440.00. The transaction was disclosed in a filing with the SEC, which is available at this link. In the last ninety days, insiders sold 24,000 shares of company stock worth $527,920. 45.80% of the stock is owned by company insiders.

A hedge fund recently raised its stake in Tabula Rasa Healthcare stock. California State Teachers Retirement System raised its position in shares of Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) by 60.2% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 16,500 shares of the company’s stock after acquiring an additional 6,200 shares during the period. California State Teachers Retirement System owned approximately 0.10% of Tabula Rasa Healthcare worth $248,000 at the end of the most recent quarter. Institutional investors and hedge funds own 27.93% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece of content was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of international trademark & copyright laws. The original version of this piece of content can be accessed at

About Tabula Rasa Healthcare

Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.

Earnings History for Tabula Rasa Healthcare (NASDAQ:TRHC)

Receive News & Stock Ratings for Tabula Rasa Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa Healthcare Inc. and related stocks with our FREE daily email newsletter.